You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Policy & Regulation
Calidi Biotherapeutics Names Heehyoung Lee to Board of Directors
Login
Username:

Password:


Related Headlines

Ten63 Therapeutics launches BEYOND-Alpha early adopter programme

Eloxx Pharmaceuticals publishes Phase 2a exaluren data in nonsense mutation Alport syndrome

Bristol Myers Squibb reports first Phase 3 data for KarXT in Alzheimer's-related psychosis

Pfizer signs licensing agreement with Starna Therapeutics worth up to USD2.63bn

DDL introduces Pharmaceutical Consulting Services for drug delivery support and combination product development

Inhibrx updates clinical data for ozekibart (INBRX-109) in Ewing sarcoma

Dicot Pharma initiates phase 2b clinical study of erectile dysfunction drug candidate

Sobi's Tryngolza for severe hypertriglyceridaemia receives EU approval

Oncoinvent reports favourable interim safety results for Radspherin in phase 2 ovarian cancer trial

Rakuten Medical launches Phase 1 first-in-human trial of PD-L1-targeted RM-0256 photoimmunotherapy

BioArctic and Eisai report positive five-year data for Leqembi in early Alzheimer's disease

Akeso submits sNDA for ivonescimab chemotherapy combination in first-line biliary tract cancer

AstraZeneca rare disease unit secures US and EU approvals for Klygefa in myasthenia gravis

Genentech secures first FDA approval for primary membranous nephropathy treatment

TRIMTECH Therapeutics partners with Biogen to develop protein degraders for neurodegenerative diseases

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026